Abstract

A study of fenfluramine was conducted among chronic schizophrenic patients. Fenfluramine tended to improve activation and global BPRS ratings, while worsening PBRS negative symptoms. Blood serotonin concentrations for each subject declined by at least 50% on active fenfluramine.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Intramural Research (Z01)
Project #
1Z01MH002271-01
Application #
4696532
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost

  Institution

Name
U.S. National Institute of Mental Health
Department
Type
DUNS #
City
State
Country
United States
Zip Code